ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,182Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 103

$813K Total Retail Price of All Prescriptions

Rank: 9 out of 103

580 Patients Receiving at Least One Drug in Part D
99%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 580 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

16% of this provider’s 580 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

1% of this provider’s 17,854 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
LEVOTHYROXINE SODIUM 847 847 1 4
WARFARIN SODIUM 703 703 2 9
FUROSEMIDE 658 652 3 6
OMEPRAZOLE 630 624 4 7
LISINOPRIL 595 581 5 2
SIMVASTATIN 535 535 6 1
DONEPEZIL HCL 496 496 7 11
AMLODIPINE BESYLATE 492 489 8 5
CITALOPRAM HBR 443 431 9 10
NAMENDA 432 432 10 16
HYDROCODONE-ACETAMINOPHEN 402 400 S3 11 3
MIRTAZAPINE 317 317 12 24
TRAMADOL HCL 293 292 13 20
METOPROLOL TARTRATE 282 282 14 8
SERTRALINE HCL 261 261 15 18
POTASSIUM CHLORIDE 260 260 16 12
GABAPENTIN 244 233 17 13
TORSEMIDE 218 207 18 134
FAMOTIDINE 210 210 19 42
CARVEDILOL 208 207 20 22
DIOVAN 198 189 21 72
CYMBALTA 191 189 22 56
ALENDRONATE SODIUM 190 181 23 25
ATENOLOL 189 189 24 19
PRAVASTATIN SODIUM 178 178 25 27
TAMSULOSIN HCL 176 165 26 30
HYDRALAZINE HCL 169 169 27 34
ZOLPIDEM TARTRATE 169 165 27 35
METOPROLOL SUCCINATE 167 167 29 17
CARBIDOPA-LEVODOPA 153 153 30 60
POLYETHYLENE GLYCOL 3350 141 137 31 32
ENABLEX 138 138 32 157
FLUTICASONE PROPIONATE 133 122 33 47
DIGOXIN 131 131 34 49
OXYBUTYNIN CHLORIDE ER 131 131 34 87
DIVALPROEX SODIUM 131 127 34 45
PANTOPRAZOLE SODIUM 119 115 37 37
TRAZODONE HCL 118 109 38 39
HYDROCHLOROTHIAZIDE 114 112 39 15
ISOSORBIDE MONONITRATE ER 113 113 40 26
QUETIAPINE FUMARATE 111 95 41 46
VENLAFAXINE HCL ER 108 108 42 90
LEVETIRACETAM 108 108 42 57
RISPERIDONE 107 97 44 41
METHADONE HCL 107 91 S2 44 106
ALLOPURINOL 107 107 44 36
CIPROFLOXACIN HCL 105 105 47 59
FINASTERIDE 102 102 48 98
GALANTAMINE HBR 98 98 49 88
KLOR-CON M10 96 96 50 120
ADVAIR DISKUS 96 96 50 43
GLIPIZIDE ER 95 95 52 123
PROPRANOLOL HCL 95 84 52 154
KLOR-CON 10 86 86 54 150
SPIRIVA 86 86 54 51
ROPINIROLE HCL 85 85 56 91
ESCITALOPRAM OXALATE 79 79 57 50
CEPHALEXIN 79 79 57 77
LEVOFLOXACIN 77 77 59 115
DILTIAZEM 24HR ER 75 75 60 107
TRIMETHOPRIM 72 72 61 230
OLANZAPINE 71 71 62 84
LANTUS 70 70 63 29
EVISTA 68 68 64 155
LANTUS SOLOSTAR 67 67 65 93
ABILIFY 66 66 66 152
NYSTATIN 64 64 67 84
BUPROPION XL 63 63 68 178
TRIAMTERENE-HCTZ 63 63 68 83
IPRATROPIUM BROMIDE 63 57 68 99
FENTANYL 60 60 S2 71 48
TRIAMCINOLONE ACETONIDE 59 59 72 108
LOSARTAN POTASSIUM 59 57 72 23
PREDNISONE 59 59 72 38
FENOFIBRATE 58 57 75 137
PAROXETINE HCL 57 57 76 74
NOVOFINE AUTOCOVER 56 56 77 251
ALPRAZOLAM 56 56 77 131
ATORVASTATIN CALCIUM 55 55 79 21
SEROQUEL 53 40 80 105
LATANOPROST 51 51 81 131
AGGRENOX 50 50 82 157
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 7, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.